Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence.
作者信息
Khan Abbas, Ali Liaqat, Wei Dong-Qing
机构信息
Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Zhongjing Research and Industrialization Institute of Chinese Medicine, Nanyang, China.
出版信息
Front Mol Biosci. 2022 Sep 28;9:1034990. doi: 10.3389/fmolb.2022.1034990. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Breast cancer resistance, biomarkers and therapeutics development in the era of artificial intelligence.
Front Mol Biosci. 2022 Sep 28;9:1034990. doi: 10.3389/fmolb.2022.1034990. eCollection 2022.
2
Editorial: An era of personalized medicine in breast cancer: integrating artificial intelligence into practice.
Front Oncol. 2023 Jun 6;13:1164808. doi: 10.3389/fonc.2023.1164808. eCollection 2023.
3
Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms.
Front Oncol. 2020 Mar 31;10:330. doi: 10.3389/fonc.2020.00330. eCollection 2020.
4
The Need for Artificial Intelligence in Digital Therapeutics.
Digit Biomark. 2020 Apr 8;4(1):21-25. doi: 10.1159/000506861. eCollection 2020 Jan-Apr.
5
Artificial intelligence and radiomics in nuclear medicine: potentials and challenges.
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2731-2736. doi: 10.1007/s00259-019-04593-0.
6
Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System.
Front Med (Lausanne). 2021 May 24;8:587496. doi: 10.3389/fmed.2021.587496. eCollection 2021.
7
New Opportunities and Challenges for Forensic Medicine in the Era of Artificial Intelligence Technology.
Fa Yi Xue Za Zhi. 2020 Feb;36(1):77-85. doi: 10.12116/j.issn.1004-5619.2020.01.016.
8
[The development of ophthalmology in artificial intelligence era].
Zhonghua Yan Ke Za Zhi. 2018 Sep 11;54(9):645-648. doi: 10.3760/cma.j.issn.0412-4081.2018.09.002.
9
Radiomics in breast MRI: current progress toward clinical application in the era of artificial intelligence.
Radiol Med. 2022 Jan;127(1):39-56. doi: 10.1007/s11547-021-01423-y. Epub 2021 Oct 26.
10
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies.
Int J Environ Res Public Health. 2020 Mar 20;17(6):2078. doi: 10.3390/ijerph17062078.
引用本文的文献
1
Machine Learning-Based Prognostic Signature in Breast Cancer: Regulatory T Cells, Stemness, and Deep Learning for Synergistic Drug Discovery.
Int J Mol Sci. 2025 Jul 21;26(14):6995. doi: 10.3390/ijms26146995.
2
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer.
Sci Data. 2023 Nov 20;10(1):815. doi: 10.1038/s41597-023-02709-8.
本文引用的文献
1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
An Integrated Systems Biology and Network-Based Approaches to Identify Novel Biomarkers in Breast Cancer Cell Lines Using Gene Expression Data.
Interdiscip Sci. 2020 Jun;12(2):155-168. doi: 10.1007/s12539-020-00360-0. Epub 2020 Feb 13.
Zotero 插件